Study ofLRRK2variation in tauopathy: Progressive supranuclear palsy and corticobasal degeneration

The phenotypic spectrum of progressive supranuclear palsy

(2016) G. Respondek et al.   PARKINSONISM & RELATED DISORDERS

Clinicopathologic and11C-Pittsburgh compound B implications of Thal amyloid phase across the Alzheimer’s disease spectrum

(2015) Melissa E. Murray et al.   BRAIN

Novel LRRK2 mutations in Parkinsonism

(2015) Joanne Trinh et al.   PARKINSONISM & RELATED DISORDERS

Clinical Correlations With Lewy Body Pathology inLRRK2-Related Parkinson Disease

(2015) Lorraine V. Kalia et al.   JAMA Neurology

Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease

(2014) Mike A Nalls et al.   NATURE GENETICS

LRRK2 exonic variants and risk of multiple system atrophy

(2014) M. G. Heckman et al.   NEUROLOGY

Novel mutation in MAPT exon 13 (p.N410H) causes corticobasal degeneration

(2013) Naomi Kouri et al.   ACTA NEUROPATHOLOGICA

Criteria for the diagnosis of corticobasal degeneration

(2013) M. J. Armstrong et al.   NEUROLOGY

Deep sequencing of theLRRK2gene in 14,002 individuals reveals evidence of purifying selection and independent origin of the p.Arg1628Pro mutation in Europe

(2012) Justin P. Rubio et al.   HUMAN MUTATION

Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case–control study

(2011) Owen A Ross et al.   LANCET NEUROLOGY

Atypical tauopathy in a patient with LRRK2-G2019S mutation and tremor-dominant Parkinsonism

(2011) C. Ruffmann et al.   NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY

Leucine-Rich Repeat Kinase 2 Gene-Associated Disease: Redefining Genotype-Phenotype Correlation

(2010) Christian Wider et al.   Neurodegenerative Diseases

Screening forLRRK2R1441 mutations in a cohort of PSP patients from Germany

(2009) D. Madžar et al.   EUROPEAN JOURNAL OF NEUROLOGY

Familial aggregation of parkinsonism in progressive supranuclear palsy

(2009) L. D. Kaat et al.   NEUROLOGY

Analysis of Lrrk2 R1628P as a risk factor for Parkinson's disease

(2008) Owen A. Ross et al.   ANNALS OF NEUROLOGY

Screening for the LRRK2 G2019S and codon-1441 mutations in a pathological series of parkinsonian syndromes and frontotemporal lobar degeneration

(2008) Carles Gaig et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES